Novel Antisense Drug Shows Promise in Slowing Fatty Liver Disease
A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
Health & Behavior
The Latest
Longitudinal Study of Brain Aging and Cognitive Change Receives $19 Million Grant
Researchers at UC San Diego School of Medicine, with colleagues elsewhere, will receive almost $19 million over five years for the fourth phase of the Vietnam Era Twin Study of Aging, which investigates cognition, aging and the risk for mild cognitive impairment and Alzheimer’s disease.
Biologist Sonya Neal Named 2020 Pew Scholar
The Pew Charitable Trusts today announced that Sonya Neal, an assistant professor in the University of California San Diego Division of Biological Sciences, has been selected to join the Pew Scholars Program in the Biomedical Sciences.
Putting ‘Super’ in Natural Killer Cells
Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
Serving the Underserved During the Global Pandemic
“A wonderful blessing” is how Donna Beifus describes the partnership between UC San Diego Health and Father Joe’s Villages, a non-profit organization serving more than 13,500 San Diegans each year who are experiencing homelessness and poverty.
Helping San Diegans Return to Work
When Gary and Jean Shekhter learned about a research alliance that could help San Diegans return to work safely through comprehensive coronavirus screenings, they were inspired to help. San Diego has been good to the couple, who came to the U.S. from the Ukraine.
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
